Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia.
Schneider-Helmert D · 1987 · European neurology 27(2):120-129
What does this source report?
A small double-blind, placebo-controlled report found better nighttime sleep and daytime performance during seven treatment nights.
- Population and setting
- 14 middle-aged patients with chronic insomnia
- Evidence type
- Clinical trial / comparison
- Preparation
- Ordinary DSIP
- Source language
- eng
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Small sample and short follow-up; allocation and complete methods require appraisal.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed metadata and abstract checked via PubMed / Europe PMC; full methods and risk-of-bias assessment pending.
Recorded source-check date: 2026-10-01. This date does not imply a completed systematic review.
Open original source or index record ↗
DOI: 10.1159/000116143
Cite and trace this record
Original source: Schneider-Helmert D. Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia. European neurology 27(2):120-129 1987.
Molekul research summary: https://molekul.io/research/dsip-3622582. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry